Enterprise Value
-836.4K
Cash
2.064M
Avg Qtr Burn
N/A
Short % of Float
0.51%
Insider Ownership
0.56%
Institutional Own.
0.00%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Arimoclomol Details Niemann Pick Disease Type C | NDA Resubmission | |
Aldoxorubicin Details Soft tissue sarcoma, Cancer | Phase 2 Update | |
Aldoxorubicin Details Pancreatic cancer | Phase 2 Update | |
Arimoclomol Details Amyotrophic lateral sclerosis | Failed Discontinued | |
Arimoclomol Details Inclusion Body Myositis | Failed Discontinued |